IMMUNOTHERAPY OF PROSTATE CANCER WITH GENETICALLY ENHANCES TUMOR-SPECIFIC T-CELL PRECURSORS

$710,378FY2009Department of the ArmyDOD

Sloan-Kettering Institute For Cancer Research

Investigators